News | Imaging Software Development | August 29, 2025

HeartFocus Introduces First U.S. Clinical Product on Butterfly Network

FDA-cleared AI-guided cardiac imaging software now available for all U.S healthcare professionals.

HeartFocus Introduces First U.S. Clinical Product on Butterfly Network

Aug. 27, 2025 – HeartFocus, the AI-enabled cardiac imaging software developed by data-driven medtech company DESKi, announced its U.S. commercial launch. HeartFocus will initially be available on Butterfly Network’s handheld ultrasound devices, the FDA-cleared software enables any healthcare professional to conduct diagnostic-quality heart ultrasounds after just hours of training. Health systems, primary care clinics, and clinical education institutions can now access the application. 

Following recent FDA clearance and a successful international clinical trial, HeartFocus has moved from pilot to full deployment, empowering healthcare professionals to conduct fast and comprehensive cardiac assessments anywhere patients are seen, from rural clinics to primary care, education, cardiology, and even in acute high-volume triage environments.

HeartFocus addresses the most persistent barriers in cardiac care: limited access to trained sonographers and long wait times for diagnostic imaging. With just hours of training, any healthcare professional using HeartFocus can capture comprehensive echocardiographic views with consistency that has been clinically proven to match expert operators. Now commercially available through Butterfly Network’s single-probe, whole-body ultrasound system, providing seamless AI integration.

Bertrand Moal, PhD, MD, CEO of DESKi said, “With HeartFocus, we’re unlocking access to life-saving heart scans wherever they’re needed most. This isn’t just a product launch, it represents phase one in our mission to transform how and where cardiac care is delivered, setting a new standard in accessibility and impact.”

Davinder Ramsingh, VP, Innovation Partnerships and Clinical Development at Butterfly Network, said, “This commercial launch marks a first within the Butterfly Garden, offering deep integration with one of the most widely adopted handheld ultrasound systems in the U.S. We’re thrilled to bring HeartFocus to healthcare professionals nationwide. By combining Butterfly’s handheld device with HeartFocus’ AI-powered software, we’re enabling earlier detection and better outcomes, from large health systems to rural, underserved communities.”

Now addressing increasing cardiac care needs, HeartFocus empowers providers of all levels to deliver timely, high-quality cardiac care, anywhere it’s needed.

To learn more, visit www.heartfocus.ai 


Related Content

News | FDA

Dec.1, 2025 – MannKind Corp. has announced that the U.S. Food and Drug Administration (FDA) has accepted the sNDA ...

Home December 01, 2025
Home
News | FDA

Nov. 18, 2025 — RapidAI announced U.S. Food and Drug Administration (FDA) clearance of Aortic Management, part of the ...

Home November 18, 2025
Home
News | FDA

Nov. 11, 2025 -— Integra LifeSciences Holdings Corp. has announced the FDA 510(k) clearance for use of its CUSA Clarity ...

Home November 18, 2025
Home
News | FDA

Nov. 10, 2025 — Stereotaxis has received U.S. Food and Drug Administration 510(k) clearance for its latest generation ...

Home November 11, 2025
Home
News | FDA

Oct. 29, 2025 — Circle Cardiovascular Imaging Inc., a provider of cardiovascular imaging solutions, recently announced ...

Home November 03, 2025
Home
News | FDA

Oct. 24, 2025 —YorLabs, Inc., a medical technology company developing next-generation intracardiac imaging solutions for ...

Home October 27, 2025
Home
News | FDA

Oct. 16, 2025 — Thirona recently announced that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance ...

Home October 16, 2025
Home
News | FDA

Oct. 14, 2025 — Nurea has announced that its PRAEVAorta 2 software has received FDA 510(k) clearance, enabling entry ...

Home October 14, 2025
Home
News | FDA

July 7, 2025 — Boston Scientific Corp. has received U.S. Food and Drug Administration (FDA) approval to expand the ...

Home July 08, 2025
Home
News | FDA

June 12, 2025 — Viz.ai recently announced it has received U.S. Food and Drug Administration (FDA) 510(k) clearance for ...

Home June 12, 2025
Home
Subscribe Now